Salada Foods Jamaica Limited (JMSE:SALF)

Ligand Pharmaceuticals Statistics

Total Valuation

JMSE:SALF has a market cap or net worth of JMD 3.25 billion. The enterprise value is 2.78 billion.

Market Cap	3.25B
Enterprise Value	2.78B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	Jun 4, 2025

Share Statistics

JMSE:SALF has 1.04 billion shares outstanding.

Current Share Class	1.04B
Shares Outstanding	1.04B
Shares Change (YoY)	n/a
Shares Change (QoQ)	-7.55%
Owned by Insiders (%)	1.91%
Owned by Institutions (%)	4.84%
Float	160.85M

Valuation Ratios

The trailing PE ratio is 18.07.

PE Ratio	18.07
Forward PE	n/a
PS Ratio	2.13
PB Ratio	2.73
P/TBV Ratio	2.73
P/FCF Ratio	17.49
P/OCF Ratio	14.77
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.65, with an EV/FCF ratio of 14.94.

EV / Earnings	15.43
EV / Sales	1.82
EV / EBITDA	11.65
EV / EBIT	13.21
EV / FCF	14.94

Financial Position

The company has a current ratio of 4.24

Current Ratio	4.24
Quick Ratio	2.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 15.52% and return on invested capital (ROIC) is 11.33%.

Return on Equity (ROE)	15.52%
Return on Assets (ROA)	9.02%
Return on Invested Capital (ROIC)	11.33%
Return on Capital Employed (ROCE)	17.67%
Revenue Per Employee	190.46M
Profits Per Employee	22.49M
Employee Count	8
Asset Turnover	1.05
Inventory Turnover	2.22

Taxes

In the past 12 months, JMSE:SALF has paid 57.96 million in taxes.

Income Tax	57.96M
Effective Tax Rate	24.36%

Stock Price Statistics

The stock price has decreased by -15.63% in the last 52 weeks. The beta is 0.12, so JMSE:SALF's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	-15.63%
50-Day Moving Average	3.22
200-Day Moving Average	3.39
Relative Strength Index (RSI)	49.21
Average Volume (20 Days)	325,449

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, JMSE:SALF had revenue of JMD 1.52 billion and earned 179.94 million in profits. Earnings per share was 0.17.

Revenue	1.52B
Gross Profit	463.02M
Operating Income	210.14M
Pretax Income	237.90M
Net Income	179.94M
EBITDA	238.31M
EBIT	210.14M
Earnings Per Share (EPS)	0.17

Balance Sheet

The company has 474.85 million in cash and n/a in debt, giving a net cash position of 474.85 million or 0.46 per share.

Cash & Cash Equivalents	474.85M
Total Debt	n/a
Net Cash	474.85M
Net Cash Per Share	0.46
Equity (Book Value)	1.19B
Book Value Per Share	1.15
Working Capital	978.00M

Cash Flow

In the last 12 months, operating cash flow was 220.17 million and capital expenditures -34.27 million, giving a free cash flow of 185.91 million.

Operating Cash Flow	220.17M
Capital Expenditures	-34.27M
Free Cash Flow	185.91M
FCF Per Share	0.18

Margins

Gross margin is 30.39%, with operating and profit margins of 13.79% and 11.81%.

Gross Margin	30.39%
Operating Margin	13.79%
Pretax Margin	15.61%
Profit Margin	11.81%
EBITDA Margin	15.64%
EBIT Margin	13.79%
FCF Margin	12.20%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 4.03%.

Dividend Per Share	0.13
Dividend Yield	4.03%
Dividend Growth (YoY)	1.61%
Years of Dividend Growth	4
Payout Ratio	73.32%
Buyback Yield	n/a
Shareholder Yield	4.03%
Earnings Yield	5.53%
FCF Yield	5.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 30, 2021. It was a forward split with a ratio of 10.

Last Split Date	Mar 30, 2021
Split Type	Forward
Split Ratio	10

Scores

JMSE:SALF has an Altman Z-Score of 10.7 and a Piotroski F-Score of 6.

Altman Z-Score	10.7
Piotroski F-Score	6